ClinicalTrials.Veeva

Menu

Effects of Pomegranate Juice on Oxidative Stress in Patients With type2 Diabetes

N

National Nutrition and Food Technology Institute

Status and phase

Completed
Phase 4

Conditions

Diabetes Type 2

Treatments

Behavioral: lifestyle modification
Dietary Supplement: pomegranate juice

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Introduction: Diabetes mellitus a chronic diseases, is the most common and important metabolic disease in human. Increased free radicals production due to hyperglycemia produces oxidative stress which worsens the disease and its complications. Pomegranate juice has antioxidant and antiatherosclerotic properties. The present study was planned to evaluate the effects of pomegranate juice consumption on glycemic control, lipid profile,blood pressure and oxidative stress in patients with type 2 diabetes

Enrollment

60 patients

Sex

All

Ages

40 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age of 40-65 years
  • Body Mass Index 18.5-30
  • Fasting blood glucose ≥ 126 mg/dl

Exclusion criteria

  • Smoking
  • insulin for blood glucose control
  • taking estrogen or progesterone (if female)
  • Taking antioxidant supplements
  • suffering from any other chronic diseases
  • Participants are also excluded if they missed more than 10% of their pomegranate juice packs

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

pomegranate juice
Experimental group
Description:
200 ml pomegranate juice + lifestyle modification
Treatment:
Dietary Supplement: pomegranate juice
control
Active Comparator group
Description:
lifestyle modification including dietary recommendations
Treatment:
Behavioral: lifestyle modification

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems